Indomethacin Use in Pain Relief During Intrauterine Device Insertion

Phase 4

Completed

• Conditions: Family Planning
• Interventions: Drug: placebo; Drug: indomethacin suppositories

• Registration Number: NCT02711358
• Lead Sponsor: Assiut University

Brief Summary

The aim of the investigators study is to test the analgesic effect of rectal indomethacin during Intrauterine device insertion.

Detailed Description

Not available

Study Timeline

• Study Start: 2016-03
• Study First Submitted: 2016-03-14
• Study First Submitted QC: 2016-03-16
• Study First Posted: 2016-03-17
• Primary Completion: 2016-07
• Study Completion: 2016-10
• Status Verified: 2016-11
• Last Update Submitted: 2016-11-28
• Last Update Posted: 2016-11-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 120

Inclusion Criteria

• Women not taken analgesics or anxiolytics in the 24 hours prior insertion
• Women not taken misoprostol prior to intrauterine device insertion
• Women who will accept to participate in the study

Exclusion Criteria

• Any contraindication to intrauterine device placement

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
placebo	placebo	placebo suppositories
indomethacin	indomethacin suppositories	indomethacin suppositories

Primary Outcome Measures

Name	Time	Method
Mean pain score during IUD insertion	intraoperative

Trial Locations

Locations (1)

Ahmed Abbas; 🇪🇬 Assiut, Cairo, Egypt